AI assistant
MEDIFAST INC — Director's Dealing 2024
Mar 19, 2024
33899_dirs_2024-03-19_29fad18e-92d0-4bbd-88b3-d8a318b22c05.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2024-03-15
Reporting Person: Chard Daniel R (Director, Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-03-15 | Common Stock | F | 608 | $36.61 | Disposed | 102622 | Direct |
| 2024-03-15 | Common Stock | F | 942 | $36.61 | Disposed | 101680 | Direct |
| 2024-03-15 | Common Stock | F | 1859 | $36.61 | Disposed | 99821 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 108598.352 | Indirect |
Footnotes
F1: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.
F2: These shares are directly owned by The Dan and Allyson Family Irrevocable Trust, for which the reporting person is the Settlor of the Trust and Investment Trustee.